News & Events

Latest News

May 2026

Welcoming Dr. Hatem Azim as our new Chief Medical Officer

We are happy to welcome Dr. Hatem Azim as our new Chief Medical Officer. A practicing medical oncologist and clinical development consultant, Dr. Azim previously served as CMO at Emergence Therapeutics and VP/Head of Clinical Development at Innate Pharma. He is also a senior medical oncologist at Cairo Cure Oncology Center and Senior Faculty at the European School of Oncology.

Master's in Oncology, University of Newcastle Upon Tyne (UK)
PhD from Université Libre de Bruxelles (Belgium)
Oncology training at the National Cancer Institute (Cairo) and European Institute of Oncology (Milan)
Breast cancer fellowship and scientific director role at Institut Jules Bordet, Brussels

Tap for info

Nov 2025

Welcoming Hamid Idrissi to our Regulatory Expert Advisory Board

Hamid Idrissi, a seasoned Regulatory Affairs and Quality leader with 20+ years of experience across medical devices, biopharma, IVDs, CDx, and AI-ML SaMD technologies, joins the Rosetta Omics Advisory Board.

VP Regulatory/Quality/Clinical at Amia.ai
Expert in PMA, 510(k), IDE, De Novo, Q-Submissions, IND, BLA, NDA pathways
Strong knowledge of EU MDR/IVDR and global registrations across EMEA, Asia, Japan, Australia, Canada & LATAM
Approvals across IVDs, CDx, ICDs, biosimilars and AI-enabled software products

Tap for info

Nov 2025

Strategic Consulting Project with ESCP & UBC Sauder MBA students

In partnership with ESCP Business School and UBC Sauder School of Business (Canada), an outstanding group of MBA students worked with Rosetta Omics on a strategic consulting project exploring our potential expansion into North America and India.

Academic Director: Prof. Harish Krishnan (UBC Sauder)
Students: Manmohan Singh, Manaal Zar, Seerat Dhaliwal, Dimitri Djuricic, Rafat Islam
Market analysis, strategic recommendations, and global perspective for North America and India
Visit and STATION F tour facilitated by UM6P GLOBAL HUBS – France

Tap for info

Oct 2025

Joining Saudi Biotechnology Accelerator

Rosetta Omics was selected for the Biotechnology Venture Readiness Program 2025, opening doors in the GCC and MENA regions.

Selection followed exchanges at the KSA Pavilion, BIO International Convention
Mentorship from KOLs, investors and SFDA representatives
Final showcase event in Riyadh, December 2025

Tap for info

Oct 2025

Joining Pfizer Healthcare Hub France, Season 5

An acceleration program by Pfizer and WILCO: 9 months of personalised mentorship to amplify our impact.

Cohort of 6 startups improving patients' and caregivers' lives
Demonstrating value for anti-cancer drug developers
Biomarker discovery, target validation and treatment-response prediction

Tap for info

Oct 2025

Member of the ESAC Network

Rosetta Omics joined the ESAC (European Society for Advanced Cancer) Network to strengthen its position in European oncology innovation.

European network of advanced cancer researchers and clinicians
Collaborations across leading academic and industrial partners
Reinforces our European footprint in precision oncology

Tap for info

26 Sep 2025

Welcoming Prof. Dominique Bagnard to our Scientific Advisory Board

A strategic collaboration with the University of Strasbourg, ESBS and INSERM begins as Prof. Bagnard joins our Scientific Advisory Board.

Renowned neuroscientist focused on brain development, neuronal connectivity and neurodegeneration
Expert in biomarker-driven drug design bridging neurobiology and oncology
Combines transcriptomics, proteomics and molecular imaging for diagnostic and predictive biomarkers

Tap for info

20 Sep 2025

International Consulting Project with ESCP Business School

Third International Consulting Project (ICP) with ESCP designs Rosetta Omics' go-to-market strategy in the USA.

Executive MBA team worked nearly a year on US market entry
Project supervised by Prof. Frédéric Jallat (KPMG Chair, ESCP)
Mentored by ESCP Alumni Stefano Scarafiotti and Elena Ivanchenko

Tap for info

Sep 2025

1st European Innovation Prize at HealthTech Innovation Days

Rosetta Omics was awarded the 1st European Innovation Prize among the top 20 European companies at HTID 2025 in Paris.

6th edition of HTIDs by HealthTech For Care
Selected jury of top KOLs in healthcare
Validation of our spatial multiomics + AI approach

Tap for info

Sep 2025

Welcoming Leonardo Cunha to our Business Advisory Board

Leonardo Cunha joins our Business Advisory Board, bringing global expertise in M&A, growth strategy, and internationalisation.

Senior leadership across Europe, Americas and Asia
MBA from Northwestern University – Kellogg School of Management
Early angel investor in Rosetta Omics

Tap for info

4 Sep 2025

Filière Intelligence Artificielle & Cancers

Dr. Wahid Awad participated in the AI & Cancer Sector Day at Bercy, fostering dialogue across France's oncology innovation ecosystem.

Held at Ministère de l'économie et des Finances, Paris
Brought together public and private actors of the oncology ecosystem
Showcased Rosetta Omics' contribution to French AI for health

Tap for info

Aug 2025

First Proof of Concept study completed in Colon Cancer

Rosetta Omics completed its first POC study in Colon Cancer, validating its predictive multiomics approach.

Integrates spatial multiomics, clinical records and AI
Aims to enhance prediction of treatment responses
Supports pharma partners in biomarker and target discovery

Tap for info

Aug 2025

Executive Board Member at Medicen Paris Region

Dr. Wahid Awad was elected Executive Board Member of Medicen Paris Region, representing pharma, biotech, medtech and diagnostics SMEs.

Founded in 2005, Medicen is the Île-de-France global competitiveness cluster
Goal: position Paris as a European industrial leader in health innovation
Translational medicine and leading-edge health technologies

Tap for info

Aug 2025

Welcoming Prof. Magali Svrcek to our Scientific Advisory Board

Prof. Magali Svrcek, world expert in gastro-intestinal pathology and AI in pathology, joined our Scientific Advisory Board.

Full Professor at Saint-Antoine Hospital, Paris
Expert in colorectal, gastric and pancreatic cancers
Pioneer in integrating AI into diagnostic pathology

Tap for info

Aug 2025

Second POC study completed in Colorectal Cancer

We completed our second POC study in CRC, three times the size of the first, in partnership with a major French university hospital.

Confirms results of the first POC study
Larger cohort with hospital-grade data
Strengthens evidence for treatment-response prediction

Tap for info

5–6 Jun 2025

HealthTech Conference by PROXIMUM 365

Dr. Wahid Awad participated in the 4th edition of the Viv Healthtech conference in Bordeaux.

Workshops, round tables and B2B meetings
Backed by Région Nouvelle-Aquitaine and Bordeaux Métropole
Connections with French healthtech innovators and investors

Tap for info

Mar 2025

Selected as Hello Tomorrow Deep Tech Pioneer

Rosetta Omics was selected among the Deep Tech Pioneers, out of 4,600 applications from 120 countries.

Recognised among the most promising deeptech ventures
Year-round access to Hello Tomorrow community
Visibility with global deeptech investors

Tap for info

Mar 2025

Welcoming Dr. Tanya Aneichyk to our Advisory Board

Dr. Tanya Aneichyk, founder & CEO of OmicsChart, joins the Advisory Board to support our biomarker and pharma strategy.

Visionary leader in cancer omics data sharing
Background at Harvard Medical School and Mass General
Expert in AI-driven diagnostics and pharma partnerships

Tap for info

Feb 2025

Welcoming Anne De Landsheer to our Advisory Board

Anne De Landsheer joins the Advisory Board, bringing 16+ years in pharma executive search and talent management.

Founder of PEAK LIFECYCLES HR (Europe & US)
Former lead of Korn Ferry's Life Sciences Practice
Board member at REGEnLIFE (Medtech)

Tap for info

Feb 2025

Joining the #NextAfrica acceleration program

Rosetta Omics joined the first cohort of the UM6P #NextAfrica program, partnered with STATION F and WILCO.

Bridge between Europe and Africa for deeptech
Collaborations with Moroccan and African hospitals
Bringing precision oncology to African patients

Tap for info

14 Jan 2025

RESI at J.P. Morgan Healthcare Week

Rosetta Omics partnered at the RESI conference during the J.P. Morgan Healthcare Week in San Francisco, USA.

Premier global healthcare investor week
Exposure to US biotech, pharma and VCs
Strategic step in our US expansion

Tap for info

Jan 2025

Welcoming Dr. Hatem Azim to our Scientific Advisory Board

Dr. Hatem Azim, leading medical oncologist and clinical development consultant, joined our Scientific Advisory Board.

Former CMO at Emergence Therapeutics, VP at Innate Pharma
Senior faculty at the European School of Oncology
PhD from Université libre de Bruxelles

Tap for info

Dec 2024

Welcoming Dr. Hugues Renaut to our Strategic Advisory Board

Rosetta Omics expands its strategic advisory board with esteemed international KOLs from the pharmaceutical industry. Dr. Hugues Renaut, PhD/MBA, joins the board.

30+ years in pharma (Servier) across Europe, Canada, China, South-America, Africa & Middle East
Former vice-chair of EFPIA European Market Committee and Patient Access Committee member
Now supports healthcare innovations as business angel (LBAN, Angels Santé) and through Health Care Advisory
Will help drive Rosetta Omics' development in precision medicine

Tap for info

11 Dec 2024

HealthTech Investor Summit, Bruges

Dr. Wahid Awad pitched Rosetta Omics to investors during the HealthTech Investor Summit in Bruges, Belgium.

Hosted by MEDVIA with 23 sponsors
Direct access to European healthtech investors
Showcase of Rosetta Omics' deeptech approach

Tap for info

Dec 2024

Welcoming Dr. Antoine Hollebecque to our Scientific Advisory Board

Dr. Antoine Hollebecque, senior medical oncologist at Gustave Roussy, joins our Scientific Advisory Board.

Principal investigator on 50+ Phase I/II/III clinical trials
Expert in biliary, pancreatic carcinomas and FGFR inhibitors
Author of 230+ peer-reviewed publications

Tap for info

Oct 2024

Welcoming Dr. Mohamed Amine Bani to our Advisory Board

Dr. Mohamed Amine Bani from Gustave Roussy joins our Advisory Board to deepen our pathology expertise.

Pathologist at Gustave Roussy
Champion of physician-driven product design
Expanding our reach to oncologists and surgeons

Tap for info

Jul 2024

First ICP with ESCP Business School

First International Consulting Project with ESCP launched at the Agoranov incubator with a top-tier Executive MBA team.

12-month go-to-market strategy project
Supervised by Prof. Frédéric Jallat
Team of 5 EMBA candidates from across Europe

Tap for info

Jun 2024

Bpifrance BFT Émergence grant

Rosetta Omics secured a Bpifrance BFT Émergence grant to finance two proof-of-concept studies in solid tumors.

Non-dilutive deeptech grant
Funds two POC studies on solid tumors
Part of the France 2030 deeptech plan

Tap for info

May 2024

Accepted at Agoranov

Rosetta Omics joined the prestigious Agoranov incubator in Paris.

Leading French incubator for deeptech and life sciences
Mentorship, resources and ecosystem access
Major milestone for our growth in France

Tap for info

Apr 2024

Membership and partnership with France Biotech

Rosetta Omics joined France Biotech, the leading voice of the French biotech ecosystem.

Access to a network of biotech leaders in France
Stronger ties with French healthcare industry
Support for innovation, investment and policy advocacy

Tap for info

Feb 2024

Partnership with Maastricht University, CircBioCare project

Rosetta Omics joined a €1.5M consortium led by Maastricht University on early detection of osteoarthritis.

Consortium with INIBIC, RIVM, OAFI and others
Funded under the Dutch KIC call (NWO + Arthritis Society)
Develops circulating epigenetic and protein biomarkers

Tap for info

2024

AI for Health French Startups Mapping 2024

Rosetta Omics is featured in the 3rd edition of the AI for Health French Startups Mapping.

191 key players across 10 categories
Recognition in Predictive Health & Early Diagnosis
Snapshot of France's healthcare AI ecosystem

Tap for info

8 Nov 2023

Entrepreneurship festival at ESCP Blue Factory

Dr. Wahid Awad pitched Rosetta Omics at the entrepreneurship festival of ESCP's Blue Factory incubator.

Theme: "Open Your Horizons"
ESCP EMBA program ranked #3 worldwide by FT 2023
Booth and pitch in front of festival attendees

Tap for info

2023

Lecture at Grenoble Ecole de Management

Dr. Wahid Awad gave a guest lecture on entrepreneurship in biopharma at Grenoble Ecole de Management.

Invited by Prof. Vittorio De Pedys
Advanced Master in Biomedical Management students
Strong interest from pharma/biotech professionals

Tap for info

HoverTap any card to see the key points.

Latest Events

11–12 Jun 2026

Amsterdam, Netherlands

Hello Tomorrow Global Summit 2026

Rosetta Omics has been named one of Hello Tomorrow's Deep Tech Pioneers. Our CEO Dr. Wahid Awad will be attending the Hello Tomorrow Global Summit on 11 and 12 June 2026 in Amsterdam to talk about precision oncology, multiomics and AI driven cancer care.

17 Mar 2026

Les Mines Paris – PSL, Paris

BioLabs European Investor Day

Rosetta Omics will attend BioLabs Europe Investor Day, part of European DeepTech Week, to connect with investors and strategic partners interested in advancing AI-driven precision oncology and our spatial and multi-omics clinical platform.

16–19 Mar 2026

Bpifrance Haussmann, Paris

European DeepTech Week

Organized by Bpifrance and EuroQuity, European DeepTech Week is a key gathering for founders, investors, corporates and innovation leaders. Rosetta Omics will connect with partners and investors who share a long-term vision for European deeptech leadership.

Mar 2026

Paris, France

ChangeNOW Summit

With action comes hope! We met visitors at our stand in the health section, in partnership with UM6P GLOBAL HUBS France. Special thanks to Mr. Jean-Pierre Farandou (Ministre du Travail et des Solidarités de France) for stopping by and for the great conversation. We were also delighted to introduce our new team member Aurore Ducamp. Rosetta Omics is changing the paradigm of cancer care by unlocking the road to precision medicine.

9–12 Feb 2026

Dubai, UAE

WHX Dubai (formerly Arab Health)

Rosetta Omics has been chosen as one of the finalists invited to pitch at the prestigious WHX Dubai. Our CEO will be pitching on 10 February in the biotech and life sciences category, looking to meet visionary investors, hospitals, pharma, biotech and medtech players.

27 Jan 2026

Innovations & Startups Village, STATION F, Paris

Grandes Tendances de la E-santé

Rosetta Omics will be at the 10th edition of this flagship e-health event, on the Pfizer Healthcare Hub France booth alongside Pfizer, WILCO Healthcare and the 5 other startups from the 5th cohort, to discuss our AI-enabled precision oncology solutions.

20 Nov 2025

Palais des Congrès d'Issy-les-Moulineaux

Phases Précoces en Cancérologie, 7th edition

Dr. Wahid Awad attended this leading academic event focused on early-phase cancer research.

13–14 Nov 2025

Innovation Garage, Allschwil, Basel, Switzerland

Trinational HealthTech Days 2025

A cross-border event uniting biotech, medtech and digital health, connecting the tri-national ecosystem of Switzerland, France and Germany. Co-organized by University of Basel, Quest for Health, Life Science Accelerator Baden-Württemberg and BadenCampus.

3–5 Nov 2025

Vienna, Austria

BIO-Europe 2025

We met investors, biotech and pharma leaders to advance partnerships in oncology and precision medicine.

8–10 Oct 2025

Cœur Défense, Paris

11th SFMPP Congress – AI and Genomics

Dr. Wahid Awad attended the 11th SFMPP (Société Française de Médecine Prédictive et Personnalisée) Congress on AI and Genomics: the twin drivers of medical innovation and personalization.

Oct 2025

Grand Palais, Paris

Adopt AI, Grand Palais

Our CEO briefly told President Emmanuel Macron at Adopt AI that Rosetta Omics is ready to be France's next AI-in-health champion and a global game changer in precision medicine. We are now raising funds to grow.

Oct 2025

Boston, USA

BIO International Convention, KSA Pavilion

A productive exchange that led to our selection in the Saudi Biotechnology Venture Readiness Program 2025.

23 Sep 2025

Accor Arena, Paris

BIG 2025 by Bpifrance

Rosetta Omics attended BIG 2025 (Bpifrance Inno Generation), the largest deeptech conference organized by Bpifrance, after participating in the 2022, 2023 and 2024 editions. An opportunity to meet Bpifrance, the European Commission, and entrepreneurs from across Europe and the world.

Sep 2025

Paris, France

HealthTech Innovation Days (HTID)

We received the 1st European Innovation Prize among the top 20 European companies.

16 Sep 2025

Future4care, Paris

AI4Immuno-Oncology Summit

Our CEO Dr. Wahid Awad participated in AI4Immuno-Oncology: Advancing Cancer Care Through AI, co-organized by Future4care and Paris Saclay Cancer Cluster, exploring how AI is transforming cancer research, therapy design and personalized treatment.

8–9 Jul 2025

Paris, France

RAISE Summit 2025

Our CEO joined the RAISE Summit, a unique gathering of innovators, scientists, investors and policy leaders shaping the future of AI and deep tech, with a focus on how AI and molecular data can drive meaningful change in healthcare.

Jun 2025

Paris, France

AI Summit by Aimfluance

Our CEO Dr. Wahid Awad was a speaker at the AI Summit hosted by Aimfluance, sharing insights on how AI is revolutionizing healthcare via Rosetta Omics.

Jun 2025

Paris, France

VivaTech 2025

Rosetta Omics joined Europe's largest tech event to showcase how AI and spatial multiomics are reshaping oncology.

12 Jun 2025

Cœur Défense, Courbevoie

Onco Startup Summit 2025 (IFODS)

Our CEO attended the Onco Startup Summit, part of the 8th French Oncology Interdisciplinary Days, jointly organized by Angels Santé, Gustave Roussy Transfert, Paris Saclay Cancer Cluster, MATWIN, OncoSTART and Réseau SATT, bringing together 200+ oncology innovation leaders.

20–21 May 2025

École Polytechnique, Paris-Saclay

Paris-Saclay SPRING 2025

Our CEO took part in one of the most vibrant innovation events in Europe, representing our mission to revolutionize cancer care through multiomics and AI alongside scientists, entrepreneurs, investors and R&D leaders.

May 2025

UM6P, Benguerir, Morocco

Deep Tech Summit (DTS) 2025

Our CEO joined 5,500+ participants from 53 countries at the second edition of the Deep Tech Summit, exploring the transformative impact of AI on deep tech across health, energy, agriculture and governance.

Apr 2025

Marrakech, Morocco

GITEX Africa 2025

Our CEO Dr. Wahid Awad spoke at the NextAfrica, Tech & Health panel and represented Rosetta Omics at the UM6P exhibition booth as part of the Next Africa program bridging Africa and Europe, discussing AI for equitable healthcare in Africa.

Mar 2025

Paris, France

Hello Tomorrow Global Summit

Selected among the Deep Tech Pioneers, we connected with leading deeptech investors and operators worldwide.